Prof Paul Cockwell speaks to ecancer at the 2019 MyKE Myeloma meeting in Barcelona about the renal complications associated with multiple myeloma.
He describes how these patients are currently managed - in which high-quality supportive care is essential, along with an accurate and prompt diagnosis.
Prof Cockwell also explains the relationship between renal recovery and the clinical outcomes of these patients, where patients with recovered kidney function experience better long-term outcomes.
He also believes the immediate and accurate detection of kidney function changes combined with the most suitable chemotherapy regimen, will help manage these patients more effectively in the future.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.